Novavax CEO Mr. Stanley Erck believes that the vaccine's earliest approvals are likely to be accorded abroad and that the company has applied in UK, EU, Korea and India. According to Indian sources, India can take a cue from the UK regulator but may proceed on the basis of strong...
Washington Galvanizes as India Battles Covid-19 Tsunami
On April 6, 2020 , as the United States was pummeled by the Covid-19 pandemic, Time Magazine lamented how India had blocked exports of a malaria drug that held potential to treat novel coronavirus patients. The President of the United States tweeted asking India for help and within just six...
Lord Lister Visits India, Prepping for U.K. Prime Minister Visit
Lord Eddie Lister, Boris Johnson’s special envoy to the Gulf countries visited India to secure millions of doses of the Oxford/AstraZeneca vaccine being manufactured under license by India’s Serum Institute. Lister and international affairs adviser David Quarrey met India’s foreign secretary Harsh Shringla in New Delhi to “discuss bilateral relations...
Codagenix, Inc., a clinical-stage biotechnology startup, has contracted with the Serum Institute of India to manufactuer CDX-005, the company's intranasal, live-attenuated vaccine candidate for SARS-CoV-2, the virus that causes COVID-19. Preclinical animal studies have been successfully completed, and the Long Island, New York company expects to initiate a Phase 1 first-in-human clinical trial in...
Codagenix, Inc., a clinical-stage biotechnology startup, has contracted with the Serum Institute of India to manufactuer CDX-005, the company's intranasal, live-attenuated vaccine candidate for SARS-CoV-2, the virus that causes COVID-19. Preclinical animal studies have been successfully completed, and the Long Island, New York company expects to initiate a Phase 1 first-in-human clinical trial in...
Serum Institute Preps for Phase 3 Trial of Covid Vaccine
Five sites across India are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Department of Biotechnology Secretary Renu Swarup said on Monday. The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to...